NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ
Fin d'année 30 Septembre 2024 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -4046.4 | -1732.056 | -515.398 | -156.686 | -96.334 | -113.375 | -182.936 |
Return on Equity (%) | 200.834 | 216.127 | -3294.686 | -230.812 | -123.778 | -149.612 | -348.409 |
Return on Invested Capital (%) | 121.263 | 184.574 | -1178.502 | -236.543 | -123.877 | -150.546 | -335.596 |
Operating Margin (%) | N/A | N/A | -317.333 | -5587.079 | -5847.953 | -607.531 | -350.101 |
Net Profit Margin (%) | N/A | N/A | -707.836 | -5588.764 | -5847.953 | -607.531 | -356.733 |
Book Value Per Share | -0.668 | -0.105 | 0.086 | 0.535 | 0.585 | 0.258 | 0.025 |
Earnings Per Share | -0.643 | -0.503 | -0.615 | -0.828 | -0.617 | -0.496 | -0.4 |
Cash Per Share | 0.003 | 0.019 | 0.182 | 0.575 | 0.503 | 0.223 | 0.047 |
Working Capital Per Share | -0.492 | -0.109 | 0.081 | 0.509 | 0.56 | 0.231 | 0.078 |
Operating Profit Per Share | N/A | N/A | 0.087 | 0.004 | 0.123 | 0.088 | 0.043 |
EBIT Per Share | -0.643 | -0.503 | -0.615 | -0.828 | -0.617 | -0.496 | -0.4 |
EBITDA Per Share | -0.643 | -0.503 | -0.615 | -0.828 | -0.617 | -0.496 | -0.4 |
Free Cash Flow Per Share | -0.634 | -0.495 | -0.612 | -0.829 | -0.607 | -0.488 | -0.404 |
Fin d'année 30 Septembre 2024 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 7,87M | 13,49M | 22,18M | 12,01M | 16,22M | N/A | 30,82M |
Fin d'année 30 Septembre 2024 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 16,24M | N/A | N/A | N/A | N/A | N/A | N/A | 30,82M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -1506.957 | N/A | N/A | N/A | -342.025 | N/A | N/A | N/A |
Net Profit Margin (%) | -1506.957 | N/A | N/A | N/A | -342.025 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 32,08M |
Ratio cours/bénéfice | -2,6 |
Ratio prix/ventes | 9,29 |
Ratio prix/liquidités | 21,99 |
Ratio prix/valeur comptable | 39,02 |
Rendement de dividende | - |
Actions en circulation | 30,84M |
Volume moyen (1 semaine) | 383,82k |
Volume moyen (1 mois) | 279,05k |
Variation sur 52 semaines | -25,71% |
Plus haut sur 52 semaines | 1,59 |
Plus bas sur 52 semaines | 0,551 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales